SPINA, Edoardo
 Distribuzione geografica
Continente #
NA - Nord America 12.754
EU - Europa 8.673
AS - Asia 6.779
SA - Sud America 3.029
AF - Africa 215
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 12
Totale 31.485
Nazione #
US - Stati Uniti d'America 12.528
SG - Singapore 2.889
BR - Brasile 2.702
IE - Irlanda 2.088
CN - Cina 1.748
SE - Svezia 1.703
IT - Italia 1.202
HK - Hong Kong 920
UA - Ucraina 901
DE - Germania 868
FI - Finlandia 457
VN - Vietnam 413
RU - Federazione Russa 366
GB - Regno Unito 337
IN - India 246
PL - Polonia 208
FR - Francia 172
AR - Argentina 115
CA - Canada 101
MX - Messico 85
TR - Turchia 72
BD - Bangladesh 71
NL - Olanda 71
ZA - Sudafrica 64
IQ - Iraq 59
BE - Belgio 58
ID - Indonesia 53
EC - Ecuador 52
ES - Italia 43
MA - Marocco 41
AT - Austria 40
UZ - Uzbekistan 40
JP - Giappone 37
CO - Colombia 36
PK - Pakistan 36
CL - Cile 35
VE - Venezuela 34
EE - Estonia 32
AE - Emirati Arabi Uniti 20
DZ - Algeria 20
AZ - Azerbaigian 19
CI - Costa d'Avorio 19
EG - Egitto 19
KE - Kenya 17
LT - Lituania 17
UY - Uruguay 17
AL - Albania 16
KZ - Kazakistan 16
AU - Australia 15
PY - Paraguay 15
TN - Tunisia 15
CZ - Repubblica Ceca 14
JO - Giordania 14
NP - Nepal 14
OM - Oman 13
PE - Perù 13
BG - Bulgaria 12
CH - Svizzera 12
JM - Giamaica 11
PH - Filippine 11
IL - Israele 10
IR - Iran 10
AM - Armenia 8
BO - Bolivia 8
GR - Grecia 8
RO - Romania 8
SN - Senegal 8
DO - Repubblica Dominicana 7
KG - Kirghizistan 7
KR - Corea 7
LB - Libano 7
LV - Lettonia 7
EU - Europa 6
PA - Panama 6
PS - Palestinian Territory 6
RS - Serbia 6
CR - Costa Rica 5
GE - Georgia 5
BN - Brunei Darussalam 4
ET - Etiopia 4
HN - Honduras 4
HR - Croazia 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
TW - Taiwan 4
BY - Bielorussia 3
DK - Danimarca 3
LK - Sri Lanka 3
NO - Norvegia 3
SA - Arabia Saudita 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
XK - ???statistics.table.value.countryCode.XK??? 3
A1 - Anonimo 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
GA - Gabon 2
GY - Guiana 2
KH - Cambogia 2
KW - Kuwait 2
Totale 31.457
Città #
Dublin 2.085
Jacksonville 1.750
Dallas 1.695
Chandler 1.522
Singapore 1.350
Ashburn 1.232
Hong Kong 917
Beijing 815
Nyköping 751
Princeton 400
Cambridge 361
Dearborn 358
Los Angeles 291
Des Moines 278
Medford 247
Messina 229
Boardman 223
The Dalles 220
São Paulo 204
Ann Arbor 194
Buffalo 191
Warsaw 190
New York 183
Ho Chi Minh City 144
Munich 136
Hyderabad 133
Wilmington 124
Moscow 116
Redondo Beach 94
Lancaster 93
Houston 91
Hanoi 87
Rio de Janeiro 86
Tianjin 84
Woodbridge 77
Jinan 75
Seattle 72
Milan 71
Turku 68
Belo Horizonte 66
San Mateo 64
Shenyang 64
Bremen 63
Brussels 57
Rome 57
Brasília 52
Nanjing 49
Pune 45
Curitiba 44
Frankfurt am Main 42
Montreal 39
Catania 38
Tashkent 36
Hangzhou 35
Hebei 34
Porto Alegre 33
Tokyo 33
Campinas 32
Haikou 32
Helsinki 32
Johannesburg 31
Santa Clara 31
Zhengzhou 30
Norwalk 29
Guangzhou 28
Baghdad 27
Taizhou 27
Denver 26
London 26
Ningbo 26
Stockholm 26
Guarulhos 25
Recife 25
Nuremberg 24
Vienna 23
Brooklyn 22
Chennai 22
Salvador 22
Boston 21
Contagem 21
Mexico City 21
San Francisco 21
Washington 21
Amsterdam 20
Biên Hòa 20
Changsha 20
Chicago 20
Abidjan 19
Baku 19
Dhaka 19
Goiânia 19
Haiphong 19
Jakarta 19
Orem 19
Poplar 19
Sorocaba 19
Dong Ket 18
Düsseldorf 18
Fortaleza 18
Guayaquil 18
Totale 19.082
Nome #
Efficacia di un trattamento aggiuntivo con olanzapina nel disturbo ossessivo-compulsivo resistente agli SSRI 355
Cutis verticis gyrata primitiva o pachidermia verticis gyrata: contributo clinico-istologico 318
Adverse Drug Reactions in Hospitalized patients: results of the FORWARD (Facilitation of reporting in hospital Ward) study. 191
Head-to-Head Comparison of Aripiprazole and Risperidone in the Treatment of ADHD Symptoms in Children with Autistic Spectrum Disorder and ADHD: A Pilot, Open-Label, Randomized Controlled Study 189
A molecular pathway analysis informs the genetic background at risk for schizophrenia. 182
Aripiprazolo in bambini con ADHD in comorbidità con Disturbo da Tic 164
Acute Cerebellar Ataxia Following Meningococcal Group C Conjugate Vaccination 163
6-Mer Hyaluronan Oligosaccharides ModulateNeuroinflammation and a-Synuclein Expression inNeuron-Like SH-SY5Y Cells 158
Confronto Teofillina-Doxofillina nella risoluzione del broncospasmo 151
Characterization and preventability of adverse drug events as cause of emergency department visits: a prospective 1-year observational study 151
"Valproic acid-amitriptyline interaction in man 149
Augmentation con Lamotrigina in pazienti con schizofrenia resistente in trattamento con Clozapina 146
A comprehensive review of swallowing difficulties and dysphagia associated with antipsychotics in adults. 145
Duloxetine in Psychiatric Disorders: Expansions Beyond Major Depression and Generalized Anxiety Disorder 141
Antidepressant use in the elderly: The role of pharmacodynamics and pharmacokinetics in drug safety 134
Serenoa repens as an Endocrine Disruptor in a 10-Year-Old Young Girl: A New Case Report 133
ABCB1 polymorphisms influence steady state plasma levels of 9-hydroxyrisperidone and risperidone active moiety. 132
A Narrative Review on Efficacy and Safety of Proton Pump Inhibitors in Children 132
Antidepressant effect of hypericum perforatum extract on behaviour and neurogenesis in chronic corticosterone-treated mice. 130
Aripiprazole in Children with Multiple-complex Developmental Disorder (McDD): a case series. 130
Low-dose of bergamot-derived polyphenolic fraction (BPF) did not improve metabolic parameters in second generation antipsychotics-treated patients: Results from a 60-days open-label study 130
Evaluation of acute cardiovascular effects of immediate-release methylphenidate in children and adolescents with attention-deficit hyperactivity disorder 129
Aripiprazole enhances the antidepressant effect of fluoxetine in mice. 128
6-MERS HYALURONAN OLIGOSACCHARIDES STIMULATE INFLAMMATORY RESPONSE IN NEURONAL-LIKE DIFFERENTIATED SH-SY5Y NEUROBLASTOMA CELLS 128
Adjunctive fluoxetine in the treatment of negative symptoms in chronic schizophrenic patients 127
Uso dell’Aripiprazolo in bambini con Multiple-complex Developmental Disorder (McDD). 126
Adverse drug interaction between risperidone and carbamazepine in a patient with chronic schizophrenia and deficient CYP2D6 activity 125
Effect of aripiprazole augmentation of serotonin reuptake inhibitors or clomipramine in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study. 125
Antidepressant drugs: prevalence, incidence and indication of use in general practice of Southern Italy during the years 2003-2004. 124
A double-blind comparative study of bromperidol versus halperidol in schizophrenic patients 124
A systematic review and combined analysis of therapeutic drug monitoring studies for long-acting risperidone. 124
PATTERN PRESCRITTIVO DI FARMACI ANTIEPILETTICI NELL'ANZIANO: STUDIO DI POPOLAZIONE IN UN'AREA DEL SUD ITALIA NEGLI ANNI 2004-2007 121
Safety and tolerability of antipsychotic drugs in pediatric patients: data from an ongoing active pharmacovigilance study in Sicily 119
Ototoxic adverse drug reactions: A disproportionality analysis using the Italian spontaneous reporting database 119
Adverse reactions related to proton pump inhibitors in pediatric population: an analysis of spontaneous reporting data 119
Adverse Drug Reactions with Drugs Used in Multiple Sclerosis: An Analysis from the Italian Pharmacovigilance Database 118
Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population 118
AN ENDOCRINOLOGIC STUDY OF PATIENTS WITH PRIMARY-CUTIS-VERTICIS GYRATA 118
Aripiprazole in Children with Multiple-complex Developmental Disorder (McDD): a case series. 118
ANTITHETIC ACTION OF HYALURONAN 6-MER IN UNDIFFERENTIATED AND DIFFERENTIATED SH-SY5Y CELLS 118
Generic Olanzapine Substitution in Patients with Schizophrenia: Assessment of Serum Concentrations and Therapeutic Response After Switching 118
No association between CYP2D6 polymorphism and Alzheimer's disease in an Italian population 117
Effect of aripiprazole augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study. XVII Congresso Nazionale della Società Italiana di Neuropsicofarmacologia, Cagliari 22-25 Settembre 2010, p. 47. 117
Augmentation of clozapine with agomelatine in partial-responder schizophrenia: A 16-week, open-label, uncontrolled pilot study 117
Lamotrigine augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study. 116
5-HT2A and 5-HT2C receptor polymorphisms and psychotic symptoms in Alzheimer's disease 114
A pharmacokinetic-pharmacodynamic method for predicting warfarin maintenance dose: preliminary results 114
Aripiprazole enhances the antidepressat effect of fluoxetine in mice. 114
Adverse drug reactions with oral anticoagulants: data from sicilian spontaneous reporting system database 114
ECG parameters in children and adolescents treated with aripiprazole and risperidone 113
Risperidone treatment of children with autistic disorder: Effectiveness, tolerability, and pharmacokinetic implications 111
Interazione farmacocinetica tra mirtazapina e clozapina in pazienti schizofrenici. 111
Effect of aripiprazole augmentation of clozapine in schizophrenia: A double-blind, placebo-controlled study. 111
“Newer and older antiepileptic drug in southern Italy: a population based study during the years 2003-2005” 110
Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update. 109
ADJUNCTIVE FLUOXETINE IN THE TREATMENT OF NEGATIVE SYMPTOMS IN CHRONIC-SCHIZOPHRENIC PATIENTS 109
A nationwide prospective study on prescribing pattern of antidepressant drugs in Italian primary care. 109
“Augmentation con Duloxetina vs. placebo in un campione di schizofrenici partial responders in trattamento stabilizzato con antipsicotici atipici”. 108
Acute cerebellar ataxia following meningococcal group C conjugate vaccination 107
Are the safety profiles of antipsychotic drugs used in dementia the same? An updated review of observational studies 107
Clinically Relevant Drug Interactions with Anti-Alzheimer's Drugs. 106
Clinically Relevant Drug Interactions Between Statins and Antidepressants 106
Antidepressant drugs and seizure susceptibility: From in vitro data to clinical practice 105
Aripiprazole augmentation of serotinin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study 105
Age-related changes in pharmacodynamics: focus on drug acting on cetral nervous and cardiovascular systems 105
Safety and tolerability of psychotropic medications in childhood: preliminary data of a pharmacovigilance study 105
Pediatric adverse reactions to antiseizure medications – An analysis of data from the Italian spontaneous reporting system (2001–2019) 105
Effetto di un trattamento con risperidone o olanzapina sui livelli serici di prolattina in bambini e adolescenti con patologie psichiatriche. 104
Indications of newer and older anti-epileptic drug use: findings from a southern Italian general practice setting from 2005-2011 104
COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety 104
Early atypical injection-site reactions to COVID-19 vaccine: a case series 103
“Effect of valproic acid on plasma concentrations of olanzapine in patients with psychiatric disorders” 103
Duloxetine as adjunctive treatment to clozapine in patients with schizophrenia: a randomized, placebo-controlled trial. 103
n-3 fatty acids prevent impairment of neurogenesis and synaptic plasticity in B-cell (BAFF) transgenic mice 102
Augmentation of Clozapine With Ziprasidone in Refractory Schizophrenia: A Double-Blind, Placebo-Controlled Study. 102
Drug-induced urinary retention: an analysis of a national spontaneous adverse drug reaction reporting database 102
Effectiveness and Safety Profiles of Biological Therapies in Inflammatory Bowel Disease: Real Life Data from an Active Pharmacovigilance Project 101
Efficacia e tollerabilità della quetiapina vs. clozapina in pazienti anziani parkinsoniani con psicosi dopaminergica. 101
Effects of aripiprazole and risperidone on ventricular repolarization in children and adolescent. 101
PARKINSONISMO ED INIBITORI SELETTIVI DEL REUPTAKE DELLA SEROTONINA 100
Tossicità cardiovascolare degli antipsicotici atipici in età evolutiva 100
Real world use of biological drugs in patients with psoriasis/psoriatic arthritis: a retrospective, population-based study from Southern Italy in the years 2010-2014 100
Quetiapine versus clozapine: a preliminary report of comparative effects on dopaminergic psychosis in patients with Parkinson's disease 98
Impiego clinico del Risperidone in età evolutiva: variazioni farmacocinetiche e cliniche 98
Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics 98
USE AND TOLERABILITY OF NEWER ANTIPSYCHOTICS AND ANTIDEPRESSANTS: A CHART REVIEW IN A PAEDIATRIC SETTING. 98
Glutamine-supplemented total parenteral nutrition improves immunological status in anorectic patients 98
Pharmacokinetic interaction between duloxetine and second-generation antipsychotics in patients with psychotic disorders 98
Adverse Drug Reactions with HER2-Positive Breast Cancer Treatment: An Analysis from the Italian Pharmacovigilance Database 98
INFLUENCE OF CYP2C9 POLYMORPHISM IN LUNG CANCER SUSCEPTIBILITY 97
Quetiapine and clozapine in parkinsonian patients with dopaminergic psychosis 96
Neuropsychiatric reactions to drugs: an analysis of spontaneous reports from general practitioners in Italy. 96
Effect of adjunctive duloxetine on the plasma concentrations of clozapine, olazapine and risperidone I patients with psychotic disorders 96
Effect of valpromide on the pharmacokinetics of Carbamazepine-10,11-epoxide 96
Safety Profile of Biologics Used in Rheumatology: An Italian Prospective Pharmacovigilance Study 96
Prescribing pattern of antiepileptic drugs in an Italian setting of elderly outpatients: a population-based study during 2004-2007 95
Red Yeast Rice (RYR) supplementation in patients treated with second-generation antipsychotics. 95
Use of antipsychotics in elderly patients with dementia: do atypical and conventional agents have a similar safety profile? 95
Assessing drug-drug interactions through therapeutic drug monitoring when administering oral second-generation antipsychotics. 94
Effectiveness and safety profile of mepolizumab in chronic rhinosinusitis with nasal polyps: Real life data in a tertiary care 93
Totale 12.100
Categoria #
all - tutte 125.121
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 125.121


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.265 0 0 0 0 0 299 56 243 56 338 133 140
2021/20222.228 27 225 31 78 50 23 133 114 83 446 293 725
2022/20235.906 509 412 218 480 521 543 52 347 2.554 28 176 66
2023/20241.672 121 246 109 169 168 338 70 102 26 164 19 140
2024/20257.254 96 95 156 401 381 220 137 1.647 1.938 446 582 1.155
2025/20267.367 911 1.411 1.804 1.471 1.592 178 0 0 0 0 0 0
Totale 31.902